In aggressive cancers such as osteosarcoma, pancreatic neuroendocrine tumors, and various high-grade sarcomas, ALT positivity is associated with genomic instability [7,10,11], therapy resistance, and poor patient survival. This evidence concerns the gene GPT and osteosarcoma.